Congress passes only veteran-focused psychedelic research funding (not broad access or rescheduling) in 2026.

Predicted 2026-07-14 · Resolves 2026-12-31 · legislation · USA

72%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

In 2026, the only psychedelic-related law Congress is likely to pass would fund research specifically for military veterans — not open up psychedelics to the general public or change their legal status. Veterans and PTSD (post-traumatic stress disorder) attract bipartisan political support in a way that broader drug policy reform simply doesn't. So lawmakers will fund studies, not freedom.

Resolution rule: YES if, as of 2026-12-31, any federal law enacted in 2026 (tracked via congress.gov) contains psychedelic-related provisions LIMITED to research/study funding (e.g., DoD/VA-directed psychedelic research), AND no enacted 2026 law reschedules or creates broad legal access to psilocybin/MDMA. NO if either no such research provision is enacted OR a broader access/rescheduling law is enacted. Checked 2026-12-31.

Research funding attracts bipartisan votes (esp. via NDAA/VA appropriations); rescheduling and broad access provisions lack the votes. The politically survivable path is narrow research language.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →